These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 18667332

  • 1. Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis.
    Lee J, Kim MS, Kim EY, Park HJ, Chang CY, Park KS, Jung DY, Kwon CH, Joh JW, Kim SJ.
    Cytokine; 2008 Oct; 44(1):49-56. PubMed ID: 18667332
    [Abstract] [Full Text] [Related]

  • 2. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis.
    Lee J, Kim MS, Kim EY, Park HJ, Chang CY, Jung DY, Kwon CH, Joh JW, Kim SJ.
    Int Immunopharmacol; 2007 Aug; 7(8):1003-12. PubMed ID: 17570317
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W.
    Int J Mol Sci; 2015 Nov 06; 16(11):26654-66. PubMed ID: 26561804
    [Abstract] [Full Text] [Related]

  • 4. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Lee KW, Kwon GY, Joh JW, Kim SJ.
    Immunol Lett; 2005 Nov 15; 101(2):210-6. PubMed ID: 16026855
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paraoxonase-1 suppresses experimental colitis via the inhibition of IFN-γ production from CD4 T cells.
    Yamashita J, Iwamura C, Ito T, Narita M, Hara Y, Sasaki T, Masuda D, Takahashi M, Tsuchiya M, Hada K, Ishikawa M, Matsuo T, Ohno Y, Tanaka H, Maruyama H, Ogawa Y, Nakayama T.
    J Immunol; 2013 Jul 15; 191(2):949-60. PubMed ID: 23772025
    [Abstract] [Full Text] [Related]

  • 8. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C.
    Pharmacol Res; 2012 Jul 15; 66(1):66-79. PubMed ID: 22475725
    [Abstract] [Full Text] [Related]

  • 9. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
    Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB.
    J Immunol; 2013 Oct 15; 191(8):4288-98. PubMed ID: 24038091
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways.
    Olejarz W, Bryk D, Zapolska-Downar D, Małecki M, Stachurska A, Sitkiewicz D.
    Eur J Clin Invest; 2014 Jan 15; 44(1):54-64. PubMed ID: 24134657
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats.
    Zeeh JM, Zorlu, Riley NE, Hoffmann P, Ruwe M, Goebell H, Gerken G, Dignass AU.
    Scand J Gastroenterol; 2001 Jan 15; 36(1):66-70. PubMed ID: 11218241
    [Abstract] [Full Text] [Related]

  • 12. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T, Yamashita K, Ichikawa N, Fukai M, Suzuki T, Goto R, Oura T, Kobayashi N, Katsurada T, Ichihara S, Ozaki M, Umezawa K, Todo S.
    J Crohns Colitis; 2012 Mar 15; 6(2):215-25. PubMed ID: 22325176
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E, Delgado M.
    Gastroenterology; 2006 Dec 15; 131(6):1799-811. PubMed ID: 17087944
    [Abstract] [Full Text] [Related]

  • 14. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
    Bai A, Guo Y, Lu N.
    Scand J Immunol; 2007 Nov 15; 66(5):538-45. PubMed ID: 17953529
    [Abstract] [Full Text] [Related]

  • 15. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
    Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T, Kotake Y.
    Antioxid Redox Signal; 2002 Feb 15; 4(1):195-206. PubMed ID: 11970853
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C, Martinez C, Juarranz MG, Arranz A, Leceta J, Delgado M, Gomariz RP.
    Gastroenterology; 2003 Apr 15; 124(4):961-71. PubMed ID: 12671893
    [Abstract] [Full Text] [Related]

  • 18. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T, Kawashima R, Kawamura YI, Otsubo T, Hagiwara T, Amatucci A, Michaelson J, Burkly LC.
    Cytokine; 2014 Sep 15; 69(1):14-21. PubMed ID: 25022957
    [Abstract] [Full Text] [Related]

  • 19. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC, Eugui EM.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette-Guérin and lipopolysaccharide.
    Yang YF, Tan DM, Xie YT, Zhao W, Hou ZH, Zhong YD.
    J Gastroenterol Hepatol; 2008 Apr 15; 23(4):611-8. PubMed ID: 17944887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.